Consun Pharmaceutical Group Limited
CPHGF
$1.08
$0.0747.34%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 17.40% | 18.33% | 11.19% | 9.51% | 11.28% |
| Total Depreciation and Amortization | -38.55% | -38.06% | -0.26% | -1.77% | 4.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.72% | -54.36% | 34.84% | 35.82% | 695.36% |
| Change in Net Operating Assets | 990.71% | 997.86% | -- | -- | -109.55% |
| Cash from Operations | 30.87% | 31.91% | 33.48% | 31.46% | -9.58% |
| Capital Expenditure | -74.11% | -75.50% | -170.65% | -166.56% | -46.61% |
| Sale of Property, Plant, and Equipment | -2,180.00% | -2,180.00% | 235.71% | 228.71% | -98.93% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 112.92% | 113.02% | -218.72% | -216.92% | -398.88% |
| Cash from Investing | 91.09% | 91.02% | -304.27% | -301.18% | -293.18% |
| Total Debt Issued | 83.78% | 83.78% | -24.45% | -24.45% | 201.78% |
| Total Debt Repaid | -229.89% | -229.89% | 0.28% | 0.28% | -97.32% |
| Issuance of Common Stock | 273.95% | 273.95% | 1,257.16% | 1,257.16% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -95.63% | -97.19% | -109.37% | -106.21% | -- |
| Other Financing Activities | 610.74% | 610.74% | -59.77% | -59.77% | -136.59% |
| Cash from Financing | -172.82% | -175.00% | -140.45% | -136.81% | -251.00% |
| Foreign Exchange rate Adjustments | 7.46% | 6.72% | -162.13% | -161.22% | -193.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 200.70% | 203.10% | -175.98% | -174.83% | -79.90% |